Epigral's Stock Reaches 52-Week High, Outperforms Sector and Market Averages

Epigral, a midcap chemical company, has recently seen a surge in its stock price, reaching a 52-week high on September 10th, 2024. The stock has been given a 'Hold' call by MarketsMOJO, a leading financial analysis platform.

According to MarketsMOJO, Epigral's stock is part of their Hidden Turnaround list since April 22nd, 2024. The company's stock has outperformed the sector by 7.49% and has been on a consecutive gain for the past 2 days, with a 9.66% increase in returns during this period. The stock also touched an intraday high of Rs 2034.95, showing a strong performance in the market.

Epigral's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market. In the past year, Epigral has shown a remarkable performance with a 91.65% increase in its stock price, while the Sensex has only seen a 23.25% growth.

Epigral is a midcap chemical company that has been gaining attention in the market due to its strong performance and potential for growth. With its recent surge in stock price and positive outlook, Epigral is definitely a company to watch out for in the chemical industry.